Bioinformatics and Drug Discovery (Record no. 247313)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 03694nam a22004575i 4500 |
001 - CONTROL NUMBER | |
control field | 978-1-59259-964-6 |
003 - CONTROL NUMBER IDENTIFIER | |
control field | DE-He213 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20160614135352.0 |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
fixed length control field | cr nn 008mamaa |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 100301s2006 xxu| s |||| 0|eng d |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9781592599646 |
-- | 978-1-59259-964-6 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1385/1592599648 |
Source of number or code | doi |
049 ## - LOCAL HOLDINGS (OCLC) | |
Holding library | Alfaisal Main Library |
050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
Classification number | RS1-441 |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MQP |
Source | bicssc |
072 #7 - SUBJECT CATEGORY CODE | |
Subject category code | MED072000 |
Source | bisacsh |
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
Classification number | 615.1 |
Edition number | 23 |
245 10 - TITLE STATEMENT | |
Title | Bioinformatics and Drug Discovery |
Medium | [electronic resource] / |
Statement of responsibility, etc | edited by Richard S. Larson. |
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE STATEMENTS | |
Place of production, publication, distribution, manufacture | Totowa, NJ : |
Name of producer, publisher, distributor, manufacturer | Humana Press, |
Date of production, publication, distribution, manufacture | 2006. |
300 ## - PHYSICAL DESCRIPTION | |
Other physical details | online resource. |
336 ## - CONTENT TYPE | |
Content Type Term | text |
Content Type Code | txt |
Source | rdacontent |
337 ## - MEDIA TYPE | |
Media Type Term | computer |
Media Type Code | c |
Source | rdamedia |
338 ## - CARRIER TYPE | |
Carrier Type Term | online resource |
Carrier Type Code | cr |
Source | rdacarrier |
347 ## - | |
-- | text file |
-- | |
-- | rda |
490 1# - SERIES STATEMENT | |
Series statement | Methods in Molecular Biology, |
International Standard Serial Number | 1064-3745 ; |
Volume number/sequential designation | 316 |
505 0# - FORMATTED CONTENTS NOTE | |
Formatted contents note | New Strategies in Drug Discovery -- Basic Microarray Analysis -- From Microarray to Biological Networks -- Microarray Analysis in Drug Discovery and Clinical Applications -- Ontology-Driven Approaches to Analyzing Data in Functional Genomics -- Gene Evolution and Drug Discovery -- Standardization of Microarray and Pharmacogenomics Data -- Clinical Applications of Bioinformatics, Genomics, and Pharmacogenomics -- Protein Interactions Probed With Mass Spectrometry -- Discovering New Drug-Targeting Sites on Flexible Multidomain Protein Kinases -- Nuclear Magnetic Resonance-Based Screening Methods for Drug Discovery -- Receptor-Binding Sites -- In Silico Protein Design -- Chemical Database Preparation for Compound Acquisition or Virtual Screening -- Bioinformatics Platform Development. |
520 ## - SUMMARY, ETC. | |
Summary, etc | Many of the new technologies that are transforming drug discovery require a high degree of interdisciplinary expertise in physical science, life science, and computer science for bioinformatic analysis of their output. In Bioinformatics and Drug Discovery, a panel of researchers from academic and pharmaceutical laboratories describes readily reproducible bioinformatic methods to advance the drug discovery process from gene identification to protein modeling to the identification of specific drug candidates. The authors demonstrate these techniques, including microarray analysis, the analysis of genes as potential drug targets, virtual screening and in silico protein design, and cheminformatics, in a variety of practical situations. Because these technologies are still emergent, each chapter contains an extended introduction that explains the theory and application of the technology and techniques described. The protocols follow the successful Methods in Molecular Biology™ series format, each offering step-by-step laboratory instructions, an introduction outlining the principles behind the technique, lists of the necessary equipment and reagents, and tips on troubleshooting and avoiding known pitfalls. Cutting-edge and highly practical, Bioinformatics and Drug Discovery makes it possible to apply in the research laboratory the powerful new technologies that promise to greatly improve and speed up the discovery of new drugs. |
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Pharmacy. |
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Pharmacy. |
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name as entry element | Pharmacy. |
655 #7 - INDEX TERM--GENRE/FORM | |
Genre/form data or focus term | Electronic books. |
Source of term | local |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Larson, Richard S. |
Relator term | editor. |
710 2# - ADDED ENTRY--CORPORATE NAME | |
Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
773 0# - HOST ITEM ENTRY | |
Title | Springer eBooks |
776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
Display text | Printed edition: |
International Standard Book Number | 9781588293466 |
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE | |
Uniform title | Methods in Molecular Biology, |
-- | 1064-3745 ; |
Volume number/sequential designation | 316 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="http://ezproxy.alfaisal.edu/login?url=http://dx.doi.org/10.1385/1592599648">http://ezproxy.alfaisal.edu/login?url=http://dx.doi.org/10.1385/1592599648</a> |
912 ## - | |
-- | ZDB-2-PRO |
942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
Source of classification or shelving scheme | Library of Congress Classification |
Koha item type | eBooks |
No items available.